Physician profile
Patrick Anderson
NPI 1376548925
$2,440.06
in general payments reported to CMS, 2019-2025
11 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.02 · 2020: $41.18 · 2021: $52.77 · 2022: $28.10 · 2023: $1,748 · 2024: $135 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334 · Travel and Lodging: $836 · Education: $30.66 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.31 |
| Travel and Lodging | $836.18 |
| Education | $30.66 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,407.97 | 2023 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $492.42 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Dilon Technologies, INC. | $149.31 | 2025 | Hemoblast Bellows |
| Baxter Healthcare | $116.51 | 2023 | Floseal |
| Astrazeneca Pharmaceuticals Lp | $109.47 | 2019-2023 | Lynparza |
| Glaxosmithkline, LLC. | $60.09 | 2020-2025 | |
| Daiichi Sankyo INC. | $36.53 | 2025 | Enhertu |
| Abbvie INC. | $20.50 | 2024 | |
| Ethicon US, LLC | $17.30 | 2019 | |
| Hologic Sales and Service, LLC | $15.58 | 2023 | Thinprep 2000 Processor, Aptima |
| Axonics, INC. | $14.38 | 2023 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.